These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17767338)

  • 1. Oral hypoglycaemic agents for diabetes in pregnancy - an appraisal of the current evidence for oral anti-diabetic drug use in pregnancy.
    Ho FL; Liew CF; Cunanan EC; Lee KO
    Ann Acad Med Singap; 2007 Aug; 36(8):672-8. PubMed ID: 17767338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral antidiabetic agents in pregnancy and lactation: a paradigm shift?
    Feig DS; Briggs GG; Koren G
    Ann Pharmacother; 2007 Jul; 41(7):1174-80. PubMed ID: 17535842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of oral hypoglycaemic agents in pregnancy.
    Holt RI; Lambert KD
    Diabet Med; 2014 Mar; 31(3):282-91. PubMed ID: 24528229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial.
    Ibrahim MI; Hamdy A; Shafik A; Taha S; Anwar M; Faris M
    Arch Gynecol Obstet; 2014 May; 289(5):959-65. PubMed ID: 24217938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.
    Cassina M; Donà M; Di Gianantonio E; Litta P; Clementi M
    Hum Reprod Update; 2014; 20(5):656-69. PubMed ID: 24861556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale, design, and methods for the Medical Optimization and Management of Pregnancies with Overt Type 2 Diabetes (MOMPOD) study.
    Berry DC; Thomas SD; Dorman KF; Ivins AR; de Los Angeles Abreu M; Young L; Boggess K
    BMC Pregnancy Childbirth; 2018 Dec; 18(1):488. PubMed ID: 30541506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
    Lautatzis ME; Goulis DG; Vrontakis M
    Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral hypoglycaemics in the first trimester and fetal outcome.
    Coetzee EJ; Jackson WP
    S Afr Med J; 1984 Apr; 65(16):635-7. PubMed ID: 6369573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulins and oral hypoglycemic agents in pregnancy.
    Homko CJ; Reece EA
    J Matern Fetal Neonatal Med; 2006 Nov; 19(11):679-86. PubMed ID: 17127490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is there a role for oral antihyperglycemics in gestational diabetes and type 2 diabetes during pregnancy?
    Homko CJ; Sivan E; Reece AE
    Treat Endocrinol; 2004; 3(3):133-9. PubMed ID: 16026109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin therapy and diabetes in pregnancy.
    Simmons D; Walters BN; Rowan JA; McIntyre HD
    Med J Aust; 2004 May; 180(9):462-4. PubMed ID: 15115425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized controlled trial.
    Feig DS; Murphy K; Asztalos E; Tomlinson G; Sanchez J; Zinman B; Ohlsson A; Ryan EA; Fantus IG; Armson AB; Lipscombe LL; Barrett JF;
    BMC Pregnancy Childbirth; 2016 Jul; 16(1):173. PubMed ID: 27435163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial.
    Løvvik TS; Carlsen SM; Salvesen Ø; Steffensen B; Bixo M; Gómez-Real F; Lønnebotn M; Hestvold KV; Zabielska R; Hirschberg AL; Trouva A; Thorarinsdottir S; Hjelle S; Berg AH; Andræ F; Poromaa IS; Mohlin J; Underdal M; Vanky E
    Lancet Diabetes Endocrinol; 2019 Apr; 7(4):256-266. PubMed ID: 30792154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study.
    Diav-Citrin O; Steinmetz-Shoob S; Shechtman S; Ornoy A
    Reprod Toxicol; 2018 Sep; 80():85-91. PubMed ID: 29857030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral hypoglycaemic agents in 118 diabetic pregnancies.
    Hellmuth E; Damm P; Mølsted-Pedersen L
    Diabet Med; 2000 Jul; 17(7):507-11. PubMed ID: 10972579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hypoglycaemic agents during pregnancy: The evidence for effectiveness and safety.
    Nicholson W; Baptiste-Roberts K
    Best Pract Res Clin Obstet Gynaecol; 2011 Feb; 25(1):51-63. PubMed ID: 21251886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is metformin ready for prime time in pregnancy? Probably not yet.
    Fantus IG
    Diabetes Metab Res Rev; 2015 Jan; 31(1):36-8. PubMed ID: 25132618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of in-utero exposure to oral hypoglycaemic drugs.
    Piacquadio K; Hollingsworth DR; Murphy H
    Lancet; 1991 Oct; 338(8771):866-9. PubMed ID: 1681225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.
    Glueck CJ; Wang P; Kobayashi S; Phillips H; Sieve-Smith L
    Fertil Steril; 2002 Mar; 77(3):520-5. PubMed ID: 11872206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.